GlassScriptPhysician profile
Nadia Vaipan
NPI 1366089104
$1,714.66
in general payments reported to CMS, 2019-2025
17 companies · $585 in 2025
The $585 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.70 · 2022: $314 · 2023: $471 · 2024: $268 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $283.58 | 2023-2025 | Odactra, Grastek, Ragwitek |
| Ironshore Pharmaceuticals INC. | $261.95 | 2022-2024 | Jornay Pm |
| Cranial Technologies, INC | $200.54 | 2022-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $186.19 | 2024-2025 | Qelbree |
| Sanofi Pasteur INC. | $133.01 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $115.87 | 2023-2025 | Gardasil 9, Enflonsia, M-M-R II |
| Collegium Pharmaceutical, INC. | $85.18 | 2025 | Jornay Pm |
| Glaxosmithkline, LLC. | $82.92 | 2022-2025 | Bexsero, Penmenvy |
| Kaleo, INC. | $70.68 | 2022 | |
| Corium, LLC | $70.56 | 2022-2023 | Azstarys |
| Tris Pharma INC | $48.23 | 2021 | |
| Phadia US INC. | $40.71 | 2021-2025 | Immunocap |
| Pfizer INC. | $36.65 | 2024-2025 | |
| Ars Pharmaceuticals Operations, INC. | $29.33 | 2025 | Neffy |
| Neurocrine Biosciences, INC. | $25.29 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $24.52 | 2025 | Voxzogo 1.2mg |
| Seqirus USA INC | $19.45 | 2023 | Flucelvax Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Vaipan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.